Author:
Ellerin Todd,Rubin Robert H.,Weinblatt Michael E.
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference52 articles.
1. Safety update on TNF-? antagonists: infliximab and etanercept. Food and Drug Administration, Center for Biologics Evaluation and Research. Arthritis Advisory Committee Meeting, August 17, 2001. Available at http://www.fda.gov/ohrms/dockets/ac/01/briefing/3779b2.htm.
2. Fatal Sepsis in a Patient With Rheumatoid Arthritis Treated With Etanercept
3. The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies
4. Tumor necrosis factor. In: editor. The cytokine handbook. 3rd ed. San Diego: Academic Press; 1998. p. 517-48.
5. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Cited by
252 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献